EODData

MEMBERSHIP REGISTER LOG IN

FRA, LGDN: Ligand Pharmaceuticals Incorporated

01 Oct 2025
LAST:

148.0

CHANGE:
 3.00		OPEN:
147.0		HIGH:
148.0		ASK:
0.0		VOLUME:
0
CHG(%):
2.07		PREV:
145.0		LOW:
147.0		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
01 Oct 25147.0148.0147.0148.00
30 Sep 25147.0147.0145.0145.00
29 Sep 25145.0145.0142.0142.024
26 Sep 25142.0142.0142.0142.024
25 Sep 25143.0143.0143.0143.024
24 Sep 25144.0144.0144.0144.024
23 Sep 25144.0144.0144.0144.024
22 Sep 25141.0141.0141.0141.024
19 Sep 25142.0142.0140.0140.024
18 Sep 25138.0138.0137.0137.024

COMPANY PROFILE

Name:Ligand Pharmaceuticals Incorporated
About:Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI, a dual endothelin and angiotensin II receptor antagonist for immunoglobulin A nephropathy; Ohtuvayre for respiratory disease; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; LYTENAVA to treat Opthamology; MEKINIST for cardiology; MINNEBRO for metabolic disease; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, JZP341, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; CE-furosemide for cardiology; CE-Meloxicam for neurology; V117, CX2101A, and Sitavig for infectious disease; REV-0100, OPT-302, and Reproxalap for opthamology; Vilazodone and Topiramate Injection for CNS; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
Sector:Healthcare
Industry:Biotechnology
Address:555 Heritage Drive, Jupiter, FL, United States, 33458
Website:https://www.ligand.com
ISIN:US53220K5048
LEI:5493008K7TB0IKP37H79

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:144.00
MA10:142.60
MA20:140.45
MA50:130.41
MA100:113.30
MA200:107.88
STO9:100.00
STO14:100.00
RSI14:71.43
MTM14:9.00
ROC14:0.06
ATR:2.57
Week High:148.00
Week Low:142.00
Month High:148.00
Month Low:135.00
Year High:148.00
Year Low:85.96
Volatility:19.06

RECENT SPLITS

Date Ratio
19 Nov 20101-6